Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2006 1
2007 2
2008 5
2009 4
2010 2
2011 2
2012 4
2013 2
2014 5
2015 9
2016 5
2017 4
2018 9
2019 13
2020 10
2021 15
2022 10
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
New treatments for dyslipidemia.
Pérez de Isla L, Valdivielso P. Pérez de Isla L, et al. Among authors: valdivielso p. Clin Investig Arterioscler. 2021 May;33 Suppl 1:1-2. doi: 10.1016/j.arteri.2021.02.003. Clin Investig Arterioscler. 2021. PMID: 33966806 Free article. English, Spanish. No abstract available.
Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.
Robinson JG, Farnier M, Krempf M, Bergeron J, Luc G, Averna M, Stroes ES, Langslet G, Raal FJ, El Shahawy M, Koren MJ, Lepor NE, Lorenzato C, Pordy R, Chaudhari U, Kastelein JJ; ODYSSEY LONG TERM Investigators. Robinson JG, et al. N Engl J Med. 2015 Apr 16;372(16):1489-99. doi: 10.1056/NEJMoa1501031. Epub 2015 Mar 15. N Engl J Med. 2015. PMID: 25773378 Free article. Clinical Trial.
Treatment of chylomicronemia.
Navarro Hermoso A, Valdivielso P. Navarro Hermoso A, et al. Among authors: valdivielso p. Clin Investig Arterioscler. 2021 May;33 Suppl 2:75-79. doi: 10.1016/j.arteri.2021.01.004. Clin Investig Arterioscler. 2021. PMID: 34006359 English, Spanish.
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial.
Ray KK, Colhoun HM, Szarek M, Baccara-Dinet M, Bhatt DL, Bittner VA, Budaj AJ, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Loizeau V, Lopes RD, Moryusef A, Murin J, Pordy R, Ristic AD, Roe MT, Tuñón J, White HD, Zeiher AM, Schwartz GG, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Ray KK, et al. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628. doi: 10.1016/S2213-8587(19)30158-5. Epub 2019 Jul 1. Lancet Diabetes Endocrinol. 2019. PMID: 31272931 Free article. Clinical Trial.
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol.
Schwartz GG, Szarek M, Bittner VA, Diaz R, Goodman SG, Jukema JW, Landmesser U, López-Jaramillo P, Manvelian G, Pordy R, Scemama M, Sinnaeve PR, White HD, Gabriel Steg P; ODYSSEY Outcomes Committees and Investigators. Schwartz GG, et al. J Am Coll Cardiol. 2021 Aug 3;78(5):421-433. doi: 10.1016/j.jacc.2021.04.102. J Am Coll Cardiol. 2021. PMID: 34325831 Free PMC article. Clinical Trial.
Quo vadis, LDL cholesterol?
Cobos A, Valdivielso P. Cobos A, et al. Among authors: valdivielso p. Adv Lab Med. 2023 May 31;4(2):133-137. doi: 10.1515/almed-2023-0051. eCollection 2023 Jun. Adv Lab Med. 2023. PMID: 38075940 Free PMC article. No abstract available.
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP).
Rizzo M, Colletti A, Penson PE, Katsiki N, Mikhailidis DP, Toth PP, Gouni-Berthold I, Mancini J, Marais D, Moriarty P, Ruscica M, Sahebkar A, Vinereanu D, Cicero AFG, Banach M; International Lipid Expert Panel (ILEP). Rizzo M, et al. Pharmacol Res. 2023 Mar;189:106679. doi: 10.1016/j.phrs.2023.106679. Epub 2023 Feb 8. Pharmacol Res. 2023. PMID: 36764041 Free article. Review.
A case of hypocholesterolemia under study.
Camacho A, Ariza MJ, Amigó N, Macías Guillén P, Sánchez Chaparro MÁ, Valdivielso P. Camacho A, et al. Among authors: valdivielso p. Clin Investig Arterioscler. 2023 Sep-Oct;35(5):244-247. doi: 10.1016/j.arteri.2023.05.003. Epub 2023 Jun 9. Clin Investig Arterioscler. 2023. PMID: 37302939 Free article. English, Spanish.
Mitochondrial Homeostasis in Obesity-related Hypertriglyceridemia.
Mela V, Ruiz-Limón P, Balongo M, Motahari Rad H, Subiri-Verdugo A, Gonzalez-Jimenez A, Soler R, Ocaña L, El Azzouzi H, Tinahones FJ, Valdivielso P, Murri M. Mela V, et al. Among authors: valdivielso p. J Clin Endocrinol Metab. 2022 Jul 14;107(8):2203-2215. doi: 10.1210/clinem/dgac332. J Clin Endocrinol Metab. 2022. PMID: 35608825 Free PMC article.
103 results